Literature DB >> 32871754

Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models.

Hannah M Hollandsworth1,2,3, Hiroto Nishino1,4, Michael Turner1,2, Siamak Amirfakhri1,2,3, Filemoni Filemoni1,2,3, Robert M Hoffman1,2,3,4, Paul J Yazaki5, Michael Bouvet6,3,3.   

Abstract

BACKGROUND/AIM: Fluorescence imaging has been shown to improve intra-operative detection of liver metastasis. The present study aimed to determine whether humanized anti-TAG-72 antibody (huCC49) conjugated to a near-infrared dye provides selective labeling of colorectal-cancer liver metastasis in orthotopic mouse models.
MATERIALS AND METHODS: Humanized anti-TAG-72 (huCC49) was conjugated to IRDye800CW (huCC49-IR800). Orthotopic liver-metastasis nude-mouse models (n=5) were established with the human colon-cancer LS174T cell-line. Three weeks later, mice were administered huCC49-IR800 and intra-vital imaging was performed 48 h later. The mean tumor-to-liver ratio (TLR) was calculated.
RESULTS: Intra-vital imaging demonstrated clear tumor margins with minimal liver fluorescence 48 h after administration of 50 μg huCC49-IR800 with mean TLR=7.53 (SD±2.76).
CONCLUSION: Anti-TAG-72 monoclonal antibody conjugated to IRDye800 provides distinct and bright labeling of colorectal tumors in orthotopic nude-mouse models of liver metastasis. TAG-72 may be a useful target for intra-operative imaging of colorectal cancer liver metastasis in the clinic. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  TAG-72; colorectal cancer orthotopic; fluorescence-guided surgery; fluorescent antibody; infrared fluorescence imaging; liver metastasis; nude mice

Mesh:

Substances:

Year:  2020        PMID: 32871754      PMCID: PMC7652487          DOI: 10.21873/invivo.12042

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  22 in total

Review 1.  TAG-72 expression and its role in the biological evaluation of human colorectal cancer.

Authors:  F Guadagni; M Roselli; M Cosimelli; P Ferroni; A Spila; F Cavaliere; R Arcuri; S Carlini; S Mariotti; G M Gandolfo; C U Casciani; J W Greiner; J Schlom
Journal:  Anticancer Res       Date:  1996 Jul-Aug       Impact factor: 2.480

Review 2.  Orthotopic is orthodox: why are orthotopic-transplant metastatic models different from all other models?

Authors:  R M Hoffman
Journal:  J Cell Biochem       Date:  1994-09       Impact factor: 4.429

3.  Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts.

Authors:  Robert M Hoffman
Journal:  Nat Rev Cancer       Date:  2015-08       Impact factor: 60.716

Review 4.  Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Authors:  R M Hoffman
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens.

Authors:  X Y Fu; J M Besterman; A Monosov; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.

Authors:  Peng Zou; Songbo Xu; Stephen P Povoski; Anna Wang; Morgan A Johnson; Edward W Martin; Vish Subramaniam; Ronald Xu; Duxin Sun
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

Review 7.  Current state of the art imaging approaches for colorectal liver metastasis.

Authors:  Bita Hazhirkarzar; Pegah Khoshpouri; Mohammadreza Shaghaghi; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293

8.  Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer.

Authors:  M Xu; F X Real; S Welt; M H Schüssler; H F Oettgen; L J Old
Journal:  Int J Cancer       Date:  1989-12-15       Impact factor: 7.396

Review 9.  Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy.

Authors:  Heather A Lillemoe; Jean-Nicolas Vauthey
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293

10.  Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases.

Authors:  Alexander R Siebenhüner; Ulrich Güller; Rene Warschkow
Journal:  BMC Cancer       Date:  2020-03-23       Impact factor: 4.430

View more
  1 in total

Review 1.  The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review.

Authors:  Michael A Turner; Thinzar M Lwin; Siamak Amirfakhri; Hiroto Nishino; Robert M Hoffman; Paul J Yazaki; Michael Bouvet
Journal:  Biomolecules       Date:  2021-12-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.